Guardant Health Expands Shield Multi-Cancer Detection Test in Asia with Manulife Partnership

Guardant Health is partnering with Manulife to launch its Shield multi-cancer detection test in Asia, expanding its international reach and linking diagnostics to insurance products outside the US. This collaboration connects Shield to an existing insurance customer base across multiple Asian countries, aligning with growing demand for earlier cancer screening and preventive care in the region. The partnership highlights Guardant Health's ability to build similar insurer relationships in other markets and may influence investor views on its valuation and growth prospects.